Form 4 holding
President and CEO, Director, 10%+ Owner
Inmune Bio, Inc.
- Security class
- Common Stock
- Shares / value
- 1,554,106
- Estimated value
- $9,907,426
- Report date
- 12 Sep 2024
- Price
- $6.38
- Ownership
- Direct
Raymond Joseph Tesi - President and CEO, Director, 10%+ Owner at Inmune Bio, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director, 10%+ Owner
- Issuer ticker
- INMB on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Raymond Joseph Tesi since 10 Aug 2025
Reported holdings for Raymond Joseph Tesi in Inmune Bio, Inc.
Form 4 holding
President and CEO, Director, 10%+ Owner
Inmune Bio, Inc.
- Security class
- Option (right to buy)
- Shares / value
- 226,000
- Estimated value
- Report date
- 05 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director, 10%+ Owner
Inmune Bio, Inc.
- Security class
- Option (right to buy)
- Shares / value
- 37,882
- Estimated value
- Report date
- 10 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director, 10%+ Owner
Inmune Bio, Inc.
- Security class
- Common Stock Warrants (right to buy)
- Shares / value
- 15,380
- Estimated value
- Report date
- 12 Sep 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Raymond Joseph Tesi in Inmune Bio, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.